InMode (INMD) Non-Current Deffered Revenue (2018 - 2025)

InMode (INMD) posted quarterly Non-Current Deffered Revenue of $3.0 million for Q4 2025, down 8.78% year-on-year from $3.3 million in Q4 2024, and down 8.78% on a QoQ basis from $3.3 million in Q4 2024.

InMode (INMD) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

InMode (INMD) has reported Non-Current Deffered Revenue for 8 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 8.78% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (down 8.78% YoY) and the FY2025 annual result came in at $3.0 million, down 8.78% from the prior year.
  • Non-Current Deffered Revenue retreated to $3.0 million in Q4 2025 per INMD's latest filing, from $3.3 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for INMD reached as high as $9.3 million in Q1 2024 and fell as low as $2.8 million in Q4 2021.
  • A 5-year average of $4.3 million and a median of $3.8 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • The largest YoY upside for Non-Current Deffered Revenue was 135.91% in 2024 against a maximum downside of 11.42% in 2024.
  • Year by year, Non-Current Deffered Revenue stood at $2.8 million in 2021, then soared by 43.91% to $4.0 million in 2022, then declined by 4.87% to $3.8 million in 2023, then retreated by 11.42% to $3.3 million in 2024, then slipped by 8.78% to $3.0 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $3.0 million, $3.3 million, and $9.3 million for Q4 2025, Q4 2024, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 183.03 Bn 175.74 Bn 6.27 Bn -
2 Stryker 129.38 Bn 126.50 Bn 3.81 Bn -
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn -
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn -
5 Edwards Lifesciences 47.66 Bn 43.99 Bn 1.29 Bn -
6 Dexcom 28.64 Bn 27.52 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn -
8 Smith & Nephew 27.02 Bn 26.44 Bn - -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn 512.79 Mn
10 InMode 975,741.41 -479.15 Mn 61.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.04 Mn
Dec 31, 2024 3.34 Mn
Mar 31, 2024 9.26 Mn
Dec 31, 2023 3.77 Mn
Mar 31, 2023 3.93 Mn
Dec 31, 2022 3.96 Mn
Dec 31, 2021 2.75 Mn
Dec 31, 2020 1.99 Mn
Dec 31, 2019 3.81 Mn
Dec 31, 2018 3.98 Mn